Corcept Therapeutics Inc (NASDAQ:CORT)
| 22.85 BATS BZX Real-Time Price As of 1:24pm ET |  +0.03 / +0.13%Today’s Change | 12.20 Today|||52-Week Range 31.18 | -12.65% Year-to-Date |
Latest CORT News | Press Releases
No recent news for Corcept Therapeutics Inc.
Today’s Trading
| Previous close | 22.82 |
| Today’s open | 22.85 |
| Day’s range | 22.52 - 22.99 |
| Volume | 21,348 |
| Average volume (3 months) | 569,711 |
| Market cap | $2.5B |
Data as of 1:24pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | +11.52% |
| Earnings growth (this year) | -0.59% |
| Earnings growth (next 5 years) | +11.55% |
| Revenue growth (last year) | +15.46% |
| P/E ratio | 29.3 |
| Price/Sales | 9.18 |
| Price/Book | 4.80 |
Competitors
| ---- | ||
| GBTGlobal Blood Therape... | -1.10 | -2.88% |
| PBHPrestige Consumer He... | -0.51 | -0.97% |
| VCELVericel Corp | +0.69 | +1.16% |
Data as of 1:24pm ET, 06/17/2021
Financials
| Next reporting date | August 3, 2021 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $353.9M |
| Annual profit (last year) | $106.0M |
| Net profit margin | 29.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Menlo Park, California |
Forecasts
